Exegenesis Bio
Building an Innovative Gene Therapy Pipeline
Philadelphia, United States · Founded 2019 · $80.0M raised
- Headquarters
- Philadelphia, Pennsylvania
- Employees
- 201–500
- Founded
- 2019
- Business Model
- B2B
- Website
- exegenesisbio.com
- Total Funding
- $80.0M
- Last Round
- $50.0M Extension RoundJun 2021
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Exegenesis Bio is a biopharmaceutical developer of gene therapies and oligonucleotide-based medicines. It is advancing an early-to-clinical-stage pipeline focused initially on central-nervous-system and ophthalmology indications, supported by integrated research and manufacturing capabilities. Its discovery platforms include computational capsid evolution, receptor-targeted capsids, artificial-intelligence-assisted gene-expression cassette design, and data-driven protein engineering to improve delivery, activity, stability, and immunogenicity.
Summary
Exegenesis Bio is a Biotech company based in Philadelphia, United States, founded in 2019. It has raised $80.0M in total across 3 rounds, most recently a $50.0M Extension Round in Jun 2021. Investors include Legend Capital, Hillhouse Capital and K2 Venture Capital.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2021
Sign up to see all 3 events
Funding: Series A through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/exegenesis-bio"><img src="https://indexed.vc/api/badge/company/exegenesis-bio" alt="Exegenesis Bio on Indexed.vc" width="260" height="76" /></a>